By: Benzinga
January 03, 2013 at 09:30 AM EST
UPDATE: Piper Jaffray Downgrades Synageva to Neutral on Lack of Near-Term Catalysts
Piper Jaffray reduced its rating on Synageva (NASDAQ: GEVA ) from Overweight to Neutral and lowered its price target from $66 to $57. Piper Jaffray noted, "We are downgrading GEVA shares to Neutral from Overweight and reducing our price target to $57 from $66 as we see absence of
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here